Skip to main content
Future Journal of Pharmaceutical Sciences
Download PDF

Qualitative and quantitative estimation of Diosgenin in coded ayurvedic formulation and its ingredient Trigonella foenum-graecum Linn. seeds used in diabetics

Future Journal of Pharmaceutical Sciences volume 7, Article number: 205 (2021) Cite this article

Abstract

Background

Trigonella foenum-graecum (Methi) is a leguminous plant and botanically known as Trigonella foenum-graecum Linn, belong to the family Fabaceae. Trigonella foenum-graecum is used for a variety of health conditions, including digestive problems, bronchitis, tuberculosis, fevers, sore throats, wounds, arthritis, abscesses, swollen glands, skin irritations, diabetes, loss of appetite, ulcers, and menopausal symptoms, as well as in the treatment of cancer. Trigonella foenum-graecum seeds mainly contain Diosgenin [(3β,25R)-spirost-5-en3-ol], a plant-derived steroid sapogenin.

Results

The identification and quantification results by HPTLC and HPLC studies of Trigonella foenum-graecum seeds hydrolysed Trigonella foenum-graecum seeds, coded formulation, hydrolysed coded formulation extract with standard Diosgenin biomarker showed a significant highest peak in hydrolysed Trigonella foenum-graecum seeds and hydrolysed coded formulation. The standard Diosgenin is observed in the hydrolysed form of hydrolysed Trigonella foenum-graecum seeds and hydrolysed coded formulation. The literature on Trigonella foenum-graecum confirms its activity as antidiabetic, and the peak of standard biomarker Diosgenin is seen after derivatization with anisaldehyde sulphuric agent, which possesses medicinal phytoconstituents value. Further related to future scientific aspects, more studies on its potent antidiabetic activity and multipurpose action need to be carried out with medicinal composition and its effects on the human body.

Conclusion

This study aims to establish the qualitative and quantitative estimation of standard Diosgenin in reliable with coded ayurvedic formulation and Trigonella foenum-graecum seeds and its activity as antidiabetic by HPTLC and HPLC.

Highlights

  • HPTLC fingerprint profile along with Diosgenin.

  • Quantification of Diosgenin by HPLC.

Background

India was enriched with a variety of herbs, shrubs, trees, and seeds used in the ancient Indian system of medicine and reported to possess beneficial medicinal effects in curing illness. Trigonella foenum-graecum is used in both forms in food and medicine in Asia. Seeds are eaten as sprouts and rich in secondary metabolites, potential sources of drugs, and essential oils of therapeutic importance. Due to their bitter taste, seeds are a good source of resin, protein, fibre, and mucilage. The critical advantages of medicinal plants' therapeutic uses in various ailments are their safety besides being economical, effective, and easy availability [1,2,3]. Our ayurvedic system praised this herb and documented its healing capacity in its ancient texts.

Among the plants known for medicinal value in Indian medicine, the plants of genus Trigonella foenum-graecum Linn belong to the family Fabaceae are vital for their therapeutic potentials. It is extensively cultivated as a semi-arid crop in northern Africa, the Mediterranean, India, and Canada [4]. Trigonella foenum-graecum (Fig. 1) grows as an erect annual with long, slender stems reaching 30–60 cm in height. The plant bears grey-green, tripartite, toothed leaves. White or pale-yellow flowers appear in summer and develop into long, slender, sword-shaped seed pods with a curved, beak-like tip. It has been reported that Trigonella foenum-graecum could be employed in the medicinal, pharmaceutical, and nutraceutical fields [5]. It is used as an aphrodisiac, astringent, demulcent, carminative, stomachic, diuretic, emmenagogue, emollient, expectorant, galactagogue, restorative, and tonic [3]. Trigonella foenum-graecum is used to treat digestive issues, bronchitis, TB, fevers, sore throats, wounds, arthritis, abscesses, swollen glands, skin irritations, diabetes, loss of appetite, ulcers, and menopausal symptoms, as well as cancer. Antidiabetic, antifertility, anticancer, antibacterial, and antiparasitic effects have been described for Trigonella foenum-graecum [3, 6]. An infusion of the leaves is used as a gargle for recurring mouth ulcers in traditional medicine. It is used as an emollient in poultices for boils, cysts, and other skin irritations. It is used to control blood pressure and lower blood sugar levels. Trigonella foenum-graecum has been shown to reduce inflammation, alleviate congestion, and fight infection. It loosens and eliminates excess mucus and phlegm, as well as relieving sinus and lung congestion. The Trigonella foenum-graecum seed is used in Chinese medicine to treat abdominal discomfort, chilblains, cholecystitis, fever, hernia, impotence, hypogastric, nephrosis, and rheumatism [7]. Trigonella foenum-graecum is known to contain alkaloids, flavonoids, salicylate, and nicotinic acid. The chemical composition of Trigonella foenum-graecum (like seeds, husk, and cotyledons) showed that endosperm had the highest saponins (4.63 g/100 g) and protein (43.8 g/100 g) content [6, 8]. T. foenum-graecum contains 45–60% galactomannans, 20–30% proteins high in lysine tryptophan, 5–10% lipids, pyridine alkaloids, trigonelline (0.2–0.38%), choline (0.5%), carpaine gentianine, flavonoids luteolin, apigenin, quercetin, orientin, isovitexin vitexin, amino as 4-hydroxyisoleucine (0.09%), histidine, arginine lysine, calcium, saponins, glycosides steroidal sapogenins on hydrolysis (yamogenin, Diosgenin, neotigogenin, tigogenin), sitosterol, cholesterol, vitamin A, B1, C, and nicotinic acid [9,10,11]. Trigonella foenum-graecum seeds mainly contain Diosgenin [(3β,25R)-spirost-5-en3-ol], a plant-derived steroid sapogenin [3, 12]. Diosgenin [(3β,25R)-spirost-5-en3-ol] (Fig. 2), a phytosteroid sapogenin, possesses several biological activities, including anticancer, hypolipidemic, anti-inflammatory, and antidiabetic ones. It also plays a beneficial role in the cardiovascular system and reduces bone loss in osteoporosis [13]. Some reported literature quantifies Diosgenin in Trigonella foenum-graecum seeds by chromatographic methods specially HPLC [14,15,16,17,18,19]. In the current study, Diosgenin was selected for qualitative and quantitative estimation in the coded formulation and Trigonella foenum-graecum seeds by HPTLC and HPLC. The aim of the present study is to develop quality control protocols for the coded ayurvedic drug by analysing the reference standard of bioactive compounds present in the formulation and respective ingredient—evaluation of HPTLC fingerprint profiling along with dominant biomarkers and estimation of bioactive markers Diosgenin by HPLC.

Fig. 1
figure 1

Plant material of Trigonella foenum-graecum Seeds

Full size image
Fig. 2
figure 2

Chemical structure of Diosgenin

Full size image

Methods

Procurement of samples

CCRAS, New Delhi, supplied coded formulation and Trigonella foenum-graecum seeds.

Reagents and standards

All chemicals and solvents were used analytical grade or HPLC grade and obtained from E-Merck and other renowned companies. The Diosgenin reference standard was procured from Natural remedies, Bengaluru, India.

Extraction procedure

Preparation of Trigonella foenum-graecum seed extract

The dried powdered seed 10.4896 g of Trigonella foenum-graecum was extracted with 200 ml of methanol using Soxhlet for 24 h. The extract was evaporated to dryness under reduced pressure. The obtained extract was collected, dried, weighed, and stored separately for further studies. The obtained extracted residue weight of extraction was 2.1845 g.

Preparation of formulation extract

The powdered 10.3038 g coded ayurvedic formulation was extracted with 200 ml of methanol using Soxhlet for 24 h. The extract was evaporated to dryness under reduced pressure. The obtained extract was collected, dried, weighed, and stored separately for further studies. The obtained residue weight of extraction was 1.2939 g.

Preparation of standard Diosgenin solution

Stock solutions of Diosgenin (0.52 mg /ml) were prepared by dissolving 5.2 mg accurately weighed standards in a small amount of HPLC grade methanol and made up the volume to 10 ml in a standard volumetric flask. The stock solution was further diluted as per the requirement for the preparation of working solutions.

Preparation of test solutions

The residues obtained from coded ayurvedic formulation and Trigonella foenum-graecum seeds were accurately weighed 50 mg each and dissolved in methanol using 10-ml volumetric flask, filtered through 0.22 μ membrane filters, and used for HPTLC fingerprint profiling and identification of reference standard Diosgenin biomarker compound.

Preparation of hydrolysed formulation and Trigonella foenum-graecum test solution

433.4 mg of Trigonella foenum-graecum seeds were weighed and extracted in 5 ml of methanol, and 4 ml of 3 N HCl was added. The above extract was refluxed for 1 h on a water bath. The solution was cooled and adjusted to pH 7 using aqueous ammonia. Make up the solution by using methanol in a 10-ml standard flask. Similarly, Ayush D was hydrolysed by weighing 500 mg extract in 5 ml of methanol, and 4 ml of 3 N HCl was added refluxed for 1 h on a water bath. The above solution was cooled and adjusted to pH 7 using aqueous ammonia. Made up to the mark in a 10-ml standard flask using methanol, filtered through 0.22 μ membrane filters, and used for HPTLC fingerprint profiling and identification of reference standard Diosgenin.

Instrumentation

HPTLC analysis

HPTLC analysis was performed on a CAMAG HPTLC system (Muttenz, Switzerland) equipped with an automatic TLC sampler IV, twin trough development chamber, TLC Scanner 3 linked with WINCATS software version 1.4.4 [20,21,22,23,24,25,26].

HPTLC fingerprint profile

The 7 µl each of the test solutions of hydrolysed Trigonella foenum-graecum seeds, Trigonella foenum-graecum seeds, hydrolysed coded formulation, coded formulation extract, and 2 µl Diosgenin standard solution was applied on a precoated silica gel 60 F254 TLC plate (E. Merck) of 0.2 mm thickness by using automatic TLC sample applicator (ATS-4). The plate was developed in a suitable solvent system of toluene/ethylacetate (9:1; v/v) in a saturated TLC chamber till the solvent rises to a distance of 8 cm.

The developed plate was dried and observed through CAMAG TLC Visualizer under UV at 254 and 366 nm, and photographs were documented. Derivatized with anisaldehyde sulphuric acid reagent and heated in a hot air oven at 105 °C until the colour of the spots appeared and the photograph was documented under white light. Before derivatization, the plate was scanned using CAMAG TLC Scanner with WINCATS software at a wavelength of UV 254 and 366 nm using deuterium lamps. After derivatization, the plate was scanned at 540 nm using a tungsten lamp.

HPLC analysis

HPLC instrumentation and chromatographic conditions

HPLC analysis was performed on an Agilent 1200 series high-performance liquid chromatographic system equipped with a quaternary pump, manual sample injector using Chemstation HPLC software. All samples and standards were filtered through 0.22 μm filters. Separation was achieved on C18 Eclipse, XDB, 4.6 mm × 50 mm, 5 μm particle size Agilent Column. The mobile phase has consisted of acetonitrile/water (95:5) (v/ v) in an isocratic elution with a flow rate of 2 ml/min, and 10 μl of the test sample (triplicate) was injected into the HPLC system. The column temperature was kept at 32 °C. The detection of analytes at 210 nm was carried out using Variable Wavelength Detector (VWD) [26, 27].

Solution A: Acetonitrile.

Solution B: Water

Good separations and suitable retention time of Diosgenin were obtained in isocratic elution using the following optimized chromatographic conditions: Column: C18 Eclipse, XDB, 4.6 mm 150 mm, 5 μm particle size. Detection: 227 nm wavelength. Detector: VWD Detector. Column temperature: 32 °C. Mobile phase: Acetonitrile: Water (95:5) (v/v). Flow rate: 2 ml/min. Injection volume: 10 μl. Mode of Operation: Isocratic elution. Retention Time: 5.278 Min. Run time: 10 min.

Quantification by HPLC

From 0.52 mg/ml Diosgenin stock solution was appropriately further diluted five different concentrations as 0.26, 0.13, 0.065, 0.0325 mg/ml of working concentrations. Each of the standard solutions was run through the HPLC system and recorded the respective peak areas. The standard calibration curve was established for peak area Vs. The concentration of Diosgenin was applied.

A 10 μl test solution of coded ayurvedic formulation, Trigonella foenum-graecum seeds, hydrolysed Trigonella foenum-graecum, and hydrolysed coded ayurvedic formulation extracts was injected in triplicate to HPLC system. Recorded the chromatogram and determined the area of the peak of the test solution corresponding to that of Diosgenin as described above from the calibration curve. The amount of Diosgenin present in the residues of coded ayurvedic formulation and Trigonella foenum-graecum seeds extract was calculated.

Results

HPTLC chromatogram gives a clear picture of standard biomarker whether it is present in ayurvedic formulations and their ingredients. RF values were calculated, and photograph documentation is recorded in Fig. 3 and Table 1. The fingerprint profile data were recorded by WIN CATS software. Details of HPTLC fingerprint profiling are given in Figs. 4, 5 and 6.

Fig. 3
figure 3

HPTLC fingerprint profiling of Trigonella foenum-graecum, coded ayurvedic formulation and Diosgenin reference standard

Full size image
Table 1 Rf values of Trigonella foenum-graecum seeds, coded ayurvedic formulation, and Diosgenin reference standard
Full size table
Fig. 4
figure 4figure 4

HPTLC fingerprint profiles of Trigonella foenum-graecum seeds extract, coded ayurvedic formulation extract and Diosgenin reference standard at UV 254 nm

Full size image
Fig. 5
figure 5figure 5

HPTLC fingerprint profiles of Trigonella foenum-graecum seeds extract, coded ayurvedic formulation extract and Diosgenin reference standard at UV 366 nm

Full size image
Fig. 6
figure 6figure 6

HPTLC Fingerprint profiles of Trigonella foenum-graecum seeds extract, coded ayurvedic formulation extract, and Diosgenin reference standard at 540 nm

Full size image

Quantification by HPLC

Calibration curve

A linear regression analysis has an equation of the form y = mx + b. The standard calibration curve was established for peak area Vs concentration of Diosgenin applied is shown in Fig. 7. Diosgenin at exp. RT: 5.278 Min, Detector: VWD, Wavelength: 210 nm, Correlation: 0.99996, Residual Std. Dev.: 5.95041 Formula: y = mx + b; m: 2884.54176; b: 7.82120 x: Amount, y: Area.

Fig. 7
figure 7

Calibration curve of Diosgenin peak area Vs concentration of Diosgenin

Full size image

Quantitative analysis

Recorded the chromatogram and determined the area of the peak of the test solution corresponding to that of Diosgenin as described above from the calibration curve given in Fig. 8. The amount of Diosgenin present in the residues of coded ayurvedic formulation and Trigonella foenum-graecum seeds extract was calculated and tabulated in Table 2.

Fig. 8
figure 8

HPLC chromatogram of Diosgenin biomarker compound in coded formulation tablet and Trigonella foenum-graecum seeds

Full size image
Table 2 Estimation of Diosgenin biomarker compound in coded ayurvedic formulation and Trigonella foenum-graecum seed
Full size table

HPLC chromatogram of standard Diosgenin and calibration curve, Ayush D tab, and Trigonella foenum-graecum seeds are given in Figs. 7 and 8.

Discussion

In the current study, qualitative Diosgenin identification was carried out using the HPTLC method, and quantitative estimation of specific biologically active Diosgenin compound was conducted in the ayurvedic coded formulation and its ingredient Trigonella foenum-graecum seed using the HPLC method [14, 15]. The HPTLC fingerprinting method is an accurate, simple, and specific method for quantifiable bioactive markers [20, 21]. HPTLC chromatogram gives a clear picture of standard biomarker whether it is present in ayurvedic formulations and their ingredients.

The HPTLC study evaluated that [11], a band in wavelength 540 nm (Green, RF 0.26) corresponding to Diosgenin is visible in both standard and test solution tracks of Trigonella foenum-graecum seeds and coded ayurvedic formulation extract.

Estimated standard Diosgenin content in coded ayurvedic formulation and Trigonella foenum-graecum seeds extracts was performed using the HPLC method. All the samples showed characteristic peaks of Diosgenin at the same retention time as that of standard Diosgenin.

The results obtained from HPLC analysis show that the Trigonella foenum-graecum seed, hydrolysed Trigonella foenum-graecum seeds, coded ayurvedic formulation, and hydrolysed coded ayurvedic formulation extracts contain 0.0504%, 0.1676%, 0.01620% and 0.0224% Diosgenin biomarker compound, respectively.

All the samples showed characteristic peaks of Diosgenin at the same retention time as that of standard Diosgenin. Retention time is 5.728 min detected at 210 nm. The results of HPLC showed that standard Diosgenin are present in Trigonella foenum-graecum seeds are 0.0109 mg/ml, hydrolysed Trigonella foenum-graecum 0.433 mg/ml, Ayush D (0.0716 mg/ml) hydrolysed coded ayurvedic formulation (0.0892 mg/ml). The amount of standard Diosgenin is tabulated in Table 2.

Conclusions

Traditional medicine plays a vital role in the healing of many ailments. Interest in herbal resources is growing day by day due to their efficacy and lesser side effects. Trigonella foenum-graecum, a leguminous plant, is botanically known as Trigonella foenum-graecum Linn, belong to the family Fabaceae. Trigonella foenum-graecum is used for various health conditions, including digestive problems, bronchitis, tuberculosis, fevers, sore throats, wounds, arthritis, abscesses, swollen glands, skin irritations, diabetes and loss of appetite, ulcers, and menopausal symptoms as well as in the treatment of cancer. Proper identification and quality control of the drug provide standard HPTLC and HPLC profiles with the selected solvent system. Major phytoconstituents are reported to be extracted in methanol and visualized under 254 nm and 366 nm. They were derivatized with the anisaldehyde sulphuric acid reagent. The Rf value of Diosgenin observed after derivatization is 0.22. The HPTLC profile can also be used to refer the proper identification/authentication of the drug. HPLC chromatogram concluded that all the samples showed characteristic peaks of Diosgenin at the same retention time as that of standard Diosgenin. The present study concludes that hydrolysed Trigonella foenum-graecum seeds and coded ayurvedic formulation give better results than the unhydrolysed form of the same with standard Diosgenin. Further studies are required to elucidate the mechanism of various phytoconstituents with the human body in treating illness.

Availability of data and materials

All data and material are available upon request.

Abbreviations

HPLC:

High-performance liquid chromatography

HPTLC:

High-performance thin-layer chromatography

RT :

Retention time

Rf :

Retention factor

TLC:

Thin-layer chromatography

VWD:

Variable wavelength detector

UV:

Ultraviolet rays

WHO:

World Health Organization

References

  1. Atal CK, Kapoor BM (1989) Cultivation and utilization of medicinal plants. Regional Research Laboratory, Council of Scientific & Industrial Research, Jammu-Tawi

    Google Scholar 

  2. Siddiqui HH (1993) Safety of herbal drugs—an overview. Drugs News Views 1(2):7–10

    Google Scholar 

  3. Meena A, Brijendra S, Uttam S, Yadav AK, Nagariya A, Sharma K (2010) Therapeutic uses and pharmacological action of Trigonella foenum-Graecum Linn. Res J Pharmacol Pharmacodyn 2(2):172–175

    Google Scholar 

  4. Kasran M, Cui SW, Goff HD (2013) Covalent attachment of fenugreek gum to soy whey protein isolate through natural Maillard reaction for improved emulsion stability. Food Hydrocolloids 30(2):552–558

    Article  CAS  Google Scholar 

  5. Zandi P, Basu SK, Khatibani LB, Balogun MO, Aremu MO, Sharma MA, Kumar R, Acharya S, Srichamroen A, Basu S, Ooraikul B, Basu T (2006) Improvement in the nutraceutical properties of fenugreek (Trigonella foenum graecum L.). J Sci Technol 28:1–9

    Google Scholar 

  6. Naidu MM, Shyamala BN, Naik PJ, Sulochanamma G, Srinivas P (2010) Chemical composition and antioxidant activity of the husk and endosperm of fenugreek seeds. Food Sci Technol 44:451–456

    Google Scholar 

  7. Duke JA, Bogenschutz-Godwin MJ, de Cellier J, Duke PK (2003) Trigonella foenum-graecum L. (Fabaceae) Trigonella foenum-graecum, Greek clover, Greek hay. In: Duke JA (ed) CRC handbook of medicinal spices, 2nd edn. CRC Press, Washington

    Google Scholar 

  8. Mehrafarin A, Qaderi A, Rezazadeh S, Naghdi BH, Noormohammadi G, Zand E (2010) Bioengineering of important secondary metabolites and metabolic pathways in Fenugreek (Trigonella foenum-graecum L.). J Med Plants Res 9(35):1–18

    CAS  Google Scholar 

  9. Budavari S (1996) The Merck index: an encyclopedia of chemicals, drugs, and biologicals, 12th edn. Merk & Co Inc, Whitehouse Station

    Google Scholar 

  10. Newall CA, Anderson LA, Phillipson JD (1996) Herbal medicines: a guide for healthcare professionals. The Pharmaceutical Press, London

    Google Scholar 

  11. Nagore DH, Patil PS, Kuber VV (2012) Comparison between high performance liquid chromatography and high-performance thin layer chromatography determination of Diosgenin from fenugreek seeds. Int J Green Pharm 6:315–320

    Article  Google Scholar 

  12. Chen YY, Tang YM, Yu SL, Han YW, Kou JP, Liu BL, Yu BY (2015) Advances in the pharmacological activities and mechanisms of Diosgenin. Chin J Nat Med 13:578–587

    CAS  PubMed  Google Scholar 

  13. Jesus M, Martins AP, Gallardo E, Silvestre S (2016) Diosgenin: Recent Highlights on pharmacology and analytical methodology. J Anal Methods Chem 2016:4156293

    Article  Google Scholar 

  14. Chaudhary SA, Chaudhary PS, Syed BA, Misra R, Bagali PG, Vitalini S, Iriti M (2018) Validation of a method for diosgenin extraction from fenugreek (Trigonella foenum-graecum L). Acta Sci Pol Technol Aliment 17(4):377–385

    CAS  PubMed  Google Scholar 

  15. Aminkar S, Shojaeiyan A, Rashidi Monfared S, Ayyari M (2018) Quantitative Assessment of diosgenin from different ecotypes of Iranian Fenugreek (L.) by high-performance liquid chromatography. J Horticult Sci 5:103–109

    CAS  Google Scholar 

  16. Sukhanov A, Stavrianidi A, Kubasova E, Panasyuk A, Buyuklinskaya O (2020) Validation of the HPLC-UV method for quantitative determination of steroid sapogenin diosgenin from Hay Fenugreek Seeds, Trigonella Foenum-graecum L. Drug Dev Reg 9:107–114

    Google Scholar 

  17. Sulakshana G, Rani AS (2014) HPLC analysis of diosgenin in three species of Costus. Int J Pharm Sci Res 5(11):747–749

    Google Scholar 

  18. Warke VB, Deshmukh TA, Patil VR (2011) Development and validation of RP-HPLC method for estimation of diosgenin in pharmaceutical dosage form. Asian J Pharm Clin Res 4:126–128

    CAS  Google Scholar 

  19. Abdalla A, Ali B, Ali M, Ali M (2014) HPTLC determination of bioactive Diosgenin for Sudanese and Indian fenugreek (Trigonellafoenum-graecum L.) seeds. Int J Adv Pharm Med Bioallied Sci 2:165–168

    Google Scholar 

  20. Sethi PD (1996) High performance thin layer chromatography, 1st edn. CBS Publishers and Distributors, New Delhi

    Google Scholar 

  21. Stahl I (1969) Thin layer chromatography. A laboratory hand book student edition. Springer, Berlin

    Google Scholar 

  22. Wagner H, Baldt S, Zgainski EM (1996) Plant drug analysis. Springer, Berlin

    Book  Google Scholar 

  23. Meena AK, Narasimhaji ChV, Velvizhi D, Singh A, Rekha P, Kumar V, Ilavarasan R, Narayana S, Dhiman KS (2018) Determination of Gallic acid in Ayurvedic polyherbal formulation Triphala churna and its ingredients by HPLC and HPTLC. Res J Pharm Technol 11(8):3243–3249

    Article  Google Scholar 

  24. Meena AK, Rekha P, Poorna V, Jayarega V, Swathi KN, Ilavarasan R (2020) Standardisation and HPTLC finger print profile of poly herbal churna, an Ayurvedic Formulation. Res J Pharm Technol 13(3):1361–1367

    Article  Google Scholar 

  25. Meena AK, Narasimhaji ChV, Rekha P, Velvizhi D, Ilavarasan R (2018) Comparative preliminary phytochemical and HPTLC fingerprint profile studies of two cinnamon species commonly used in ASU formulations. Asian J Res Chem 11(2):344–350

    Article  Google Scholar 

  26. Meena AK, Rekha P, Perumal A, Ilavarasan R, Singh R, Srikant N, Dhiman KS (2021) Identification and estimation of bioactive constituents Negundoside, Berberine chloride, and Marmelosin by HPLC and HPTLC for development of quality control protocols for Ayurvedic medicated oil formulation. Future J Pharm Sci 7(1):171

    Article  Google Scholar 

  27. Gurav N, Solanki B, Gadhvi I, Patel P, Sen D (2015) RP-HPLC method development and validation for estimation of Withaferin-A in ranger capsule. Int J Pharm Sci Res 6(12):5141–5146

    CAS  Google Scholar 

Download references

Acknowledgements

The authors are very grateful to the Director-General, CCRAS, Ministry of AYUSH, New Delhi, for providing encouragement and facilities for carrying out this work.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Regional Ayurveda Research Institute, CCRAS, Ministry of AYUSH, Gwalior, 474009, India

    Ajay Kumar Meena & Vandana Bharthi

  2. Captain Srinivasa Murthy Central Ayurveda Research Institute, CCRAS, Chennai, 600106, India

    K. N. Swathi & R. Ilavarasan

  3. Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India, New Delhi, 110058, India

    Arjun Singh & N. Srikanth

Authors
  1. Ajay Kumar Meena
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. N. Swathi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Ilavarasan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arjun Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vandana Bharthi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Srikanth
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AKM and SKN have performed the experimental work. AKM, RI, NS, and AS worked in experimental design. AKM has written the manuscript, VB also helped in manuscript writing. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Ajay Kumar Meena.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meena, A.K., Swathi, K.N., Ilavarasan, R. et al. Qualitative and quantitative estimation of Diosgenin in coded ayurvedic formulation and its ingredient Trigonella foenum-graecum Linn. seeds used in diabetics. Futur J Pharm Sci 7, 205 (2021). https://doi.org/10.1186/s43094-021-00354-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43094-021-00354-9

Keywords